Trials / Conditions / Refractory Malignant Ascites

Refractory Malignant Ascites

5 registered clinical trials studyying Refractory Malignant Ascites.

Status	Trial	Sponsor	Phase
Unknown	Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites NCT05303844	Fudan University	Phase 1
Withdrawn	Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology NCT02477657	Abramson Cancer Center at Penn Medicine	—
Completed	Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites NCT04771676	Fudan University	Phase 2
Completed	Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascite NCT02891369	Fondation Hôpital Saint-Joseph	—
Unknown	Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites NCT01852409	Peking University	Phase 1